Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients is a research paper published in PLoS Computational Biology (2023). On theSindex it has a DataRank of 0.403. It has been cited 11 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.0300
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Defense Sciences Office, DARPA
Grant: HR0011-20-2-0040
Medical Scientist Training Program
Grant: T32GM007618
National Institute of General Medical Sciences
Grant: R35GM138353
NIAMS NIH HHS
Grant: P30 AR070155
University of California, San Francisco, Program for Breakthrough Biomedical Research grant
Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
Christopher Hess Research Fund
FWCI
2.02
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals